Aug
08
2020
Indoco Remedies gets USFDA nod for schizophrenia, bipolar disorder treatment drug
Indoco Remedies Managing Director Aditi Kare Panandikar said this approval from the US health regulator will further supplement the solid dosage business for Indoco in the US.